Drug usage evaluation: clarithromycin as sequential therapy
Dempsey, C.L.; Kaley, T.C.; Zenkel, J.
Hospital Formulary 28(12): 999-1001
1993
ISSN/ISBN: 0098-6909 PMID: 10130382 Document Number: 420417
A drug usage evaluation (DUE) of the new macrolide antibiotic clarithromycin was conducted at Christ Hospital and Medical Center, an 824-bed community teaching hospital in Oak Lawn, Illinois. The purpose of this DUE was to determine whether clarithromycin was being used as early sequential therapy following other parenteral antimicrobials as recommended by the Pharmacy and Therapeutics Committee.
Document emailed within 1 workday
Related Documents
Sylvia, L.M. 1991: A departmental model for drug-usage evaluation Topics in Hospital Pharmacy Management 11(1): 46-52Mason, N.A.; Iacobellis, D.P. 1992: Drug usage evaluation of epoetin in chronic renal failure Hospital Formulary 27(9): 928
Kier, K.L.; Pathak, D.S. 1991: Drug-usage evaluation: traditional versus outcome-based approaches Topics in Hospital Pharmacy Management 11(1): 9-15
Hiraishi, M.; Konishi, T.; Makuuchi, M. 1995: Clinical evaluation of sequential MTX/5-FU therapy for gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(8): 994-1000
Halczuk, I.; Lipa, A.; Mitosek-Szewczyk, K.; Sobolewski, P.; Stelmasiak, Z.; Kaczyński, K. 2015: Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI) Wiadomosci Lekarskie 68(4 Part 2): 680-689
Benninger, P.; Cooper, A.; Moisan, R.; Patel, P.; Elvin, A.; Thiessen, J.J. 2004: A comparative clarithromycin bioavailability study: determination of clarithromycin and 14-(R)-hydroxyclarithromycin under fasting and fed conditions International Journal of Clinical Pharmacology and Therapeutics 42(6): 342-349
Zheng, X.-L.; Hu, F.-L.; Wang, W.-H.; Xu, L. 2009: Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains Zhonghua Yi Xue Za Zhi 89(22): 1558-1562
Yamamoto, F.; Harada, S.; Mitsuyama, T.; Harada, Y.; Kitahara, Y.; Yoshida, M.; Nakanishi, Y. 2004: Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin Japanese Journal of Antibiotics 57(1): 124-133
Gelisse, P.; Hillaire-Buys, D.; Halaili, E.; Jean-Pastor, M. , J.; Vespignan, H.; Coubes, P.; Crespel, A. 2007: Carbamazepine and clarithromycin: a clinically relevant drug interaction Revue Neurologique (Paris) 163(11): 1096-1099
Miller, R.R. 1974: Drug surveillance and drug usage studies: what are they and how do they differ? American Journal of Hospital Pharmacy 31(5): 492-493
Jackson, J.E.; Tally, J.D.; Ellis, W.Y.; Mebrahtu, Y.B.; Lawyer, P.G.; Were, J.B.; Reed, S.G.; Panisko, D.M.; Limmer, B.L. 1990: Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy American Journal of Tropical Medicine and Hygiene 43(5): 464-480
Liou, J-Ming.; Chen, C-Yi.; Wu, M-Shiang.; Hsu, M-Tse.; Fang, C-Chung.; Lin, Y-Ling.; Chang, M-Chu.; Lin, J-Town.; Wang, H-Po. 2006: Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease Hepato-Gastroenterology 53(71): 792-796
Furukawa, S.; Okada, T. 1989: A clinical evaluation of clarithromycin in the treatment of pediatric infections Japanese Journal of Antibiotics 42(2): 420-422
Gevaudan, M.J.; Bollet, C.; de Micco, P. 1994: Evaluation of the extra- and intracellular activity of clarithromycin against Mycobacterium chelonae Pathologie-Biologie 42(5): 412-418
Savonitto, S.; Ambrosini, V.; Marzocchi, A.; Tolaro, S.; Petronio, A.S.; Galassi, A.R.; Bongo, A.S.; Gaglione, A.; Bolognese, L. 2005: Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 106-118
2013: Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial Japanese Journal of Antibiotics 66 Suppl A: 27-31
Tomiyama, Y.; Maesaki, S.; Yong, B.; Higashiyama, Y.; Miyazaki, Y.; Tomono, K.; Tashiro, T.; Kohno, S. 1999: The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection Kekkaku: 74(5): 457-461
Iwahashi, K.; Fukamauchi, F.; Aoki, J.; Kurihara, K.; Yoshihara, E.; Inoue, M.; Shibanai, H.; Ishigooka, J. 2010: A daycare program of animal assisted therapy for affective disorder patients during psychotropic drug therapy: evaluation of the relaxation effect by fNIRS (functional near-infrared spectroscopy) Nihon Shinkei Seishin Yakurigaku Zasshi 30(3): 129-134
Hamada, K.; Sakamoto, M.; Mikasa, K.; Teramoto, M.; Mori, K.; Tsujimoto, M.; Maeda, K.; Konishi, M.; Sawaki, M.; Narita, N.; Kita, E. 1997: Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells Japanese Journal of Antibiotics 50 Suppl A: 28-31
Feldstein, T.J.; Swegarden, J.L.; Atwood, G.F.; Peterson, C.D. 1995: Ribavirin therapy: implementation of hospital guidelines and effect on usage and cost of therapy Pediatrics 96(1 Pt 1): 14-17